Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Vol 5, №4 (2024) > Metabolomic profiling in patients with rheumatoid arthritis (a pilot study)

Metabolomic profiling in patients with rheumatoid arthritis (a pilot study)

Larisa M. Musaeva , Irina V. Menshikova , Svetlana A. Appolonova , Ksenya M. Shestakova

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Background. Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by progressive joint damage and leading to early disability in patients. The main purpose of its treatment is to alleviate the pain caused by the disease, delay the development of the disease, reduce the morbidity rate, and improve the quality of life of patients. At present the specificity and sensitivity of RA diagnosis methods are not convincing. In recent decades, research has focused on pathogenesis and the discovery of potential biomarkers using new and high-precision methods, in particular metabolomics. Metabolomics is an science studying low molecular weight compounds (metabolites) involved in biochemical processes and being the end products of metabolism. Metabolites reflect the current state of the humans body and can therefore serve as perspective biomarkers.
Aim. To study the metabolomic profile of patients with RA without therapy in order to search for potential biomarkers for diagnosis and evaluation of therapy.
Material and methods. The main study group consisted of 14 patients with a newly diagnosed RA – de novo RA. 16 healthy volunteers formed the control group. Metabolites in blood plasma were studied using ultra-performance liquid chromatography in combination with a triple quadrupole analyzer. A total of 93 metabolites were analyzed in de novo RA patients and healthy controls. In the group of RA patients the relationship of these metabolites with DAS28 activity, CRP, ESR, the presence of RF and ACCP were analyzed.
Results. The most significant metabolites that play an important role in the pathogenesis of RA were identified: leucine/isoleucine, tyrosine, lysine, valine, phenylalanine, proline, ornithine, glutamine aspartate and long-chain acylcarnitines (C14, C14-OH, C16-1, C18). We found a correlation between DAS28 and leucine (p=0.03) and proline (p=0.05) levels. An inverse correlation was established between ACCP and glutamine (p=0,041) and a direct correlation between ACCP and proline (p=0.039), an inverse correlation between RF and phenylalanine (p=0.0491) and histidine (p=0.04).
Conclusion. Metabolomics provides promising opportunities for further research in RA as it allows to identify metabolites most associated with disease, which can improve the accuracy of RA diagnosis and serve as targets for therapy
Keywords: rheumatoid arthritis, metabolomic profiling, metabolomics, biomarkers.

About the Author

Larisa M. Musaeva 1 , Irina V. Menshikova 1 , Svetlana A. Appolonova 1 , Ksenya M. Shestakova 1

1 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

References

1. Filipowicz-Sosnowska A. Drug-free remission: the goal of the future in management of patients with rheumatoid arthritis. Reumatologia 2017;55(6):284-9.
2. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365(23):2205-19.
3. Scherer HU, Häupl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun 2020;110:102400.
4. Ревматоидный артрит. Клинические рекомендации. Утверждены Минздравом России. 2021.
Rheumatoid arthritis. Clinical recommendations. Approved by the Russian Ministry of Health. 2021 (in Russian).
5. Martinez-Prat L, Nissen MJ, Lamacchia C et al. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance. Front Immunol 2018;9:1113. Published 2018 Jun 6.
6. Riccardi A, Martinroche G, Contin-Bordes C et al. Erosive arthritis autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2022;52:151947.
7. Wang Z, Long H, Chang C et al. Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview. Cell Mol Life Sci 2018;75(18):3353-69.
8. Glocker MO, Guthke R, Kekow J, Thiesen HJ. Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med Res Rev 2006;26(1):63-87.
9. Madsen R, Lundstedt T, Trygg J. Chemometrics in metabolomics – a review in human disease diagnosis. Anal Chim Acta 2010;659(1-2):23-33.
10. Rinschen MM, Ivanisevic J, Giera M, Siuzdak G. Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol 2019;20(6):353-67.
11. Leichtle AB, Nuoffer JM, Ceglarek U et al. Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics 2012;8(4):
643–53.
12. Hisamatsu T, Okamoto S, Hashimoto M et al. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease. PLoS One 2012;7(1):e31131.
13. Madsen RK, Lundstedt T, Gabrielsson J, et al. Diagnostic properties of metabolic perturbations in rheumatoid arthritis. Arthritis Res Ther 2011;13(1):R19.
14. Semerano L, Roméo PH, Boissier MC. Metabolomics for rheumatic diseases: has the time come? Ann Rheum Dis 2015;74(7):1325-6.
15. Yang XY, Zheng KD, Lin K et al. Energy Metabolism Disorder as a Contributing Factor of Rheumatoid Arthritis: A Comparative Proteomic and Metabolomic Study. PLoS One 2015;10(7):e0132695.
16. Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity 2007;27(2):173-8.
17. Ouyang X, Dai Y, Wen JL, Wang LX. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus. Lupus 2011;20(13):1411-20.
18. Li J, Che N, Xu L et al. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis. Clin Rheumatol 2018;37(6):1493-502.
19. Pandhare J, Donald SP, Cooper SK, Phang JM. Regulation and function of proline oxidase under nutrient stress. J Cell Biochem 2009;107(4):759-68.
20. Andonian BJ, Johannemann A, Hubal MJ et al. Altered skeletal muscle metabolic pathways, age, systemic inflammation, and low cardiorespiratory fitness associate with improvements in disease activity following high-intensity interval training in persons with rheumatoid arthritis. Arthritis Res Ther 2021;23(1):187. Published 2021 Jul 10.
21. Mason DJ. The role of glutamate transporters in bone cell signalling.
J Musculoskelet Neuronal Interact 2004;4(2):128-31.
22. Lauridsen MB, Bliddal H, Christensen R et al. 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. J Proteome Res 2010;9(9):4545-53.

For citation:Musaeva L.M., Menshikova I.V., Appolonova S.A., Shestakova K.M. Metabolomic profiling in patients with rheumatoid arthritis (a pilot study). Clinical review for general practice. 2024; 5 (4): 76–82 (In Russ.). DOI: 10.47407/kr2024.5.4.00422


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru